Correlation Between Soluble Klotho and Chronic Kidney Disease-mineral and Bone Disorder in Chronic Kidney Disease: a Meta-analysis

Overview

Journal Sci Rep

Specialty Science

Date 2024 Feb 23

PMID 38396063

Authors

Zhongyu Fan

Xuejiao Wei

Xiaoyu Zhu

Kun Yang

Ling Tian

Yujun Du

Liming Yang

Affiliations

Soon will be listed here.

Abstract

We conducted a systematic search across medical databases, including PubMed, Web of Science, EMBASE, and Cochrane Library, up to March 2023. A total of 1944 subjects or individuals from 17 studies were included in our final analysis. The correlation coefficient (r) between sKlotho and calcium was [0.14, (0.02, 0.26)], and a moderate heterogeneity was observed (I = 66%, P < 0.05). The correlation coefficient (r) between Klotho and serum phosphate was [- 0.21, (- 0.37, - 0.04)], with apparent heterogeneity (I = 84%, P < 0.05). The correlation coefficient (r) between sKlotho and parathyroid hormone and vascular calcification was [- 0.23,(- 0.29, - 0.17); - 0.15, (- 0.23, - 0.08)], with no significant heterogeneity among the studies. (I = 40%, P < 0.05; I = 30%, P < 0.05). A significant correlation exists between low sKlotho levels and an increased risk of CKD-MBD in patients with CKD. According to the findings, sKlotho may play a role in alleviating CKD-MBD by lowering phosphorus and parathyroid hormone levels, regulating calcium levels, and suppressing vascular calcification. As analysis showed that sKlotho has an important impact on the pathogenesis and progression of CKD-MBD in CKD patients. Nonetheless, further comprehensive and high-quality studies are needed to validate our conclusions.

Citing Articles

Associations between the intake of single and multiple dietary vitamins and depression risk among populations with chronic kidney disease.

Yu C, Liu K, Yao W, Tang D Front Nutr. 2025; 12:1492829.

PMID: 39968398 PMC: 11832393. DOI: 10.3389/fnut.2025.1492829.

Chronic kidney disease.

Romagnani P, Agarwal R, Chan J, Levin A, Kalyesubula R, Karam S Nat Rev Dis Primers. 2025; 11(1):8.

PMID: 39885176 DOI: 10.1038/s41572-024-00589-9.

Severe Coronary Artery Calcifications in Chronic Kidney Disease Patients, Coupled with Inflammation and Bone Mineral Disease Derangement, Promote Major Adverse Cardiovascular Events through Vascular Remodeling.

Morena-Carrere M, Jaussent I, Chenine L, Dupuy A, Bargnoux A, Leray-Moragues H Kidney Blood Press Res. 2024; 50(1):33-45.

PMID: 39602894 PMC: 11844697. DOI: 10.1159/000542418.

References

Galitzer H, Ben-Dov I, Silver J, Naveh-Many T . Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease. Kidney Int. 2009; 77(3):211-8. DOI: 10.1038/ki.2009.464. View

Pazianas M, Miller P . Osteoporosis and Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Back to Basics. Am J Kidney Dis. 2021; 78(4):582-589. DOI: 10.1053/j.ajkd.2020.12.024. View

Hu L, Napoletano A, Provenzano M, Garofalo C, Bini C, Comai G . Mineral Bone Disorders in Kidney Disease Patients: The Ever-Current Topic. Int J Mol Sci. 2022; 23(20). PMC: 9603742. DOI: 10.3390/ijms232012223. View

Glassock R, Warnock D, Delanaye P . The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol. 2016; 13(2):104-114. DOI: 10.1038/nrneph.2016.163. View

Chen Y, Chen Y, Huang C, Duan Z, Xu C . The Clinical Value of Klotho and FGF23 in Cardiac Valve Calcification Among Patients with Chronic Kidney Disease. Int J Gen Med. 2021; 14:857-866. PMC: 7979336. DOI: 10.2147/IJGM.S299197. View

Buchanan S, Combet E, Stenvinkel P, Shiels P . Klotho, Aging, and the Failing Kidney. Front Endocrinol (Lausanne). 2020; 11:560. PMC: 7481361. DOI: 10.3389/fendo.2020.00560. View

Desbiens L, Sidibe A, Ung R, Fortier C, Munger M, Wang Y . FGF23-klotho axis, bone fractures, and arterial stiffness in dialysis: a case-control study. Osteoporos Int. 2018; 29(10):2345-2353. DOI: 10.1007/s00198-018-4598-2. View

Yokoyama K, Imura A, Ohkido I, Maruyama Y, Yamazaki Y, Hasegawa H . Serum soluble α-klotho in hemodialysis patients. Clin Nephrol. 2012; 77(5):347-51. DOI: 10.5414/cn107204. View

Dalton G, Xie J, An S, Huang C . New Insights into the Mechanism of Action of Soluble Klotho. Front Endocrinol (Lausanne). 2017; 8:323. PMC: 5715364. DOI: 10.3389/fendo.2017.00323. View

10.

Sakan H, Nakatani K, Asai O, Imura A, Tanaka T, Yoshimoto S . Reduced renal α-Klotho expression in CKD patients and its effect on renal phosphate handling and vitamin D metabolism. PLoS One. 2014; 9(1):e86301. PMC: 3900516. DOI: 10.1371/journal.pone.0086301. View

11.

Kitagawa M, Sugiyama H, Morinaga H, Inoue T, Takiue K, Ogawa A . A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease. PLoS One. 2013; 8(2):e56695. PMC: 3576368. DOI: 10.1371/journal.pone.0056695. View

12.

Cozzolino M, Galassi A, Conte F, Mangano M, Di Lullo L, Bellasi A . Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide. Ther Clin Risk Manag. 2017; 13:679-689. PMC: 5461056. DOI: 10.2147/TCRM.S108490. View

13.

Ide N, Olauson H, Sato T, Densmore M, Wang H, Hanai J . In vivo evidence for a limited role of proximal tubular Klotho in renal phosphate handling. Kidney Int. 2016; 90(2):348-362. DOI: 10.1016/j.kint.2016.04.009. View

14.

Di Lullo L, Gorini A, Bellasi A, Morrone L, Rivera R, Russo L . Fibroblast growth factor 23 and parathyroid hormone predict extent of aortic valve calcifications in patients with mild to moderate chronic kidney disease. Clin Kidney J. 2015; 8(6):732-6. PMC: 4655786. DOI: 10.1093/ckj/sfv073. View

15.

Olauson H, Lindberg K, Amin R, Sato T, Jia T, Goetz R . Parathyroid-specific deletion of Klotho unravels a novel calcineurin-dependent FGF23 signaling pathway that regulates PTH secretion. PLoS Genet. 2013; 9(12):e1003975. PMC: 3861040. DOI: 10.1371/journal.pgen.1003975. View

16.

Oh H, Nam B, Lee M, Kim C, Koo H, Doh F . Decreased circulating klotho levels in patients undergoing dialysis and relationship to oxidative stress and inflammation. Perit Dial Int. 2014; 35(1):43-51. PMC: 4335927. DOI: 10.3747/pdi.2013.00150. View

17.

Mehrotra R . Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients. J Ren Nutr. 2006; 16(2):100-18. DOI: 10.1053/j.jrn.2006.01.006. View

18.

Chalhoub D, Marques E, Meirelles O, Semba R, Ferrucci L, Satterfield S . Association of Serum Klotho with Loss of Bone Mineral Density and Fracture Risk in Older Adults. J Am Geriatr Soc. 2016; 64(12):e304-e308. PMC: 5173411. DOI: 10.1111/jgs.14661. View

19.

Kendrick J, Chonchol M . The role of phosphorus in the development and progression of vascular calcification. Am J Kidney Dis. 2011; 58(5):826-34. PMC: 3199354. DOI: 10.1053/j.ajkd.2011.07.020. View

20.

Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View